Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
2005.
Current awareness: Pharmacoepidemiology and drug safety.
Pharmacoepidemiology and Drug Safety,
Vol. 14,
Issue. 9,
Corti, Natascia
and
Imhof, Alexander
2008.
A worldwide yearly survey of new data and trends in adverse drug reactions and interactions.
Vol. 30,
Issue. ,
p.
297.
Wall, G Michael
Stroman, David W.
Roland, Peter S.
and
Dohar, Joseph
2009.
Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspension for the Topical Treatment of Ear Infections.
Pediatric Infectious Disease Journal,
Vol. 28,
Issue. 2,
p.
141.
House, Joyce Colton
and
Lee, Daniel J.
2010.
Cummings Otolaryngology - Head and Neck Surgery.
p.
1950.
Shaw, Kathryn A.
Babu, Kavita M.
and
Hack, Jason B.
2011.
Methadone, another Cause of Opioid-associated Hearing Loss: A Case Report.
The Journal of Emergency Medicine,
Vol. 41,
Issue. 6,
p.
635.
Wysocki, Jarosław
and
Bartoszewicz, Robert
2013.
Bezpieczeństwo miejscowego dousznego stosowania leków w różnych sytuacjach klinicznych.
Polski Przegląd Otorynolaryngologiczny,
Vol. 2,
Issue. 2,
p.
86.
Mohindra, Satyawati
Mohindra, Sandeep
Gupta, Karan
Gupta, Bhumika
and
Singh, Dharamveer
2015.
Hearing Loss with Amphotericin B Therapy in Patients with Rhinocerebral Aspergillosis: Is it a Reality?.
Journal of Postgraduate Medicine, Education and Research,
Vol. 49,
Issue. 2,
p.
66.
Chen, Chih-Hao
Wang, Ching-Yuan
Cheng, Meng-Yu
Hsih, Wen-Hsin
Tien, Ni
Chou, Chia-Huei
Lin, Po-Chang
Chi, Chih-Yu
Ho, Mao-Wang
and
Lu, Min-Chi
2022.
Definite therapy of mixed infection alleviates refractory dilemma of adult chronic suppurative otitis media.
Journal of Microbiology, Immunology and Infection,
Vol. 55,
Issue. 6,
p.
1283.
McDermott, John Henry
Wolf, Joshua
Hoshitsuki, Keito
Huddart, Rachel
Caudle, Kelly E.
Whirl‐Carrillo, Michelle
Steyger, Peter S.
Smith, Richard J. H.
Cody, Neal
Rodriguez‐Antona, Cristina
Klein, Teri E.
and
Newman, William G.
2022.
Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT‐RNR1 Genotype.
Clinical Pharmacology & Therapeutics,
Vol. 111,
Issue. 2,
p.
366.